Publications by authors named "E G Dmitrienko"

Recent advances in genetics and nucleic acid chemistry have created fundamentally new tools, both for practical applications in therapy and diagnostics and for fundamental genome editing tasks. Nucleic acid-based therapeutic agents offer a distinct advantage of selectively targeting the underlying cause of the disease. Nevertheless, despite the success achieved thus far, there remain unresolved issues regarding the improvement of the pharmacokinetic properties of therapeutic nucleic acids while preserving their biological activity.

View Article and Find Full Text PDF

Aptamers are currently being investigated for their potential to improve virotherapy. They offer several advantages, including the ability to prevent the aggregation of viral particles, enhance target specificity, and protect against the neutralizing effects of antibodies. The purpose of this study was to comprehensively investigate an aptamer capable of enhancing virotherapy.

View Article and Find Full Text PDF

Lipophilic oligonucleotide derivatives are a potent approach to the intracellular delivery of nucleic acids. The binding of these derivatives to serum albumin is a determinant of their fate in the body, as its structure contains several sites of high affinity for hydrophobic compounds. This study focuses on the features of self-association and non-covalent interactions with human serum albumin of novel self-penetrating oligonucleotide derivatives.

View Article and Find Full Text PDF

Biomaterial-mediated, spatially localized gene delivery is important for the development of cell-populated scaffolds used in tissue engineering. Cells adhering to or penetrating into such a scaffold are to be transfected with a preloaded gene that induces the production of secreted proteins or cell reprogramming. In the present study, we produced silica nanoparticles-associated pDNA and electrospun scaffolds loaded with such nanoparticles, and studied the release of pDNA from scaffolds and cell-to-scaffold interactions in terms of cell viability and pDNA transfection efficacy.

View Article and Find Full Text PDF
Article Synopsis
  • A newly discovered long non-coding RNA (lncRNA) associated with DNA damage in human cells may play a role in the treatment of non-small cell lung cancer (NSCLC) when treated with cisplatin.
  • Using the A549 lung adenocarcinoma cell line, researchers found that overexpressing this lncRNA increases the cells' sensitivity to cisplatin, while silencing it decreases sensitivity.
  • The lncRNA enhances stability and activates a specific signaling pathway, suggesting it could serve as a potential therapeutic target to combat cisplatin resistance in NSCLC.
View Article and Find Full Text PDF